Assignee
TOOLGEN INC
KR·19 granted patents·42 pending applications·95 citations·filing 2003–2025
Top patents by PatentIndex Score
61 records- 0197US10851380B2Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas proteinTOOLGEN INC·Filed 2015·Granted Dec 1, 2020·47 cites·10 claims
- 0296US10519454B2Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGENTOOLGEN INC·Filed 2017·Granted Dec 31, 2019·15 cites·13 claims
- 0391US7514257B2Zinc finger transcription factor differentiation proteinsTOOLGEN INC·Filed 2003·Granted Apr 7, 2009·32 cites·15 claims
- 0491US2025066798A1Compositions for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cellsTOOLGEN INC·Filed 2024·Application pending·0 cites
- 0591US2025122509A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2024·Application pending·0 cites
- 0689US12473559B2Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cellsTOOLGEN INC·Filed 2023·Granted Nov 18, 2025·0 cites·8 claims
- 0786US2023374525A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0886US2023374524A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0983US12509697B2Oleic acid-enriched plant body having genetically modified FAD2 and production method thereofTOOLGEN INC·Filed 2023·Granted Dec 30, 2025·0 cites·1 claims
- 1077US2025171788A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1176US2026043013A1Single base substitution protein, and composition comprising sameTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1275US2025146002A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1375US2021047647A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2020·Application pending·0 cites
- 1475US2021047648A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2020·Application pending·0 cites
- 1574US12486521B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2023·Granted Dec 2, 2025·0 cites·13 claims
- 1674US12286635B2Oleic acid-enriched plant body having genetically modified FAD2 and production method thereofTOOLGEN INC·Filed 2022·Granted Apr 29, 2025·0 cites·7 claims
- 1772US11441135B2Target-specific CRISPR mutantTOOLGEN INC·Filed 2018·Granted Sep 13, 2022·1 cites·6 claims
- 1871US2024301424A1Manipulated immunoregulatory element and immunity altered therebyTOOLGEN INC·Filed 2024·Application pending·0 cites
- 1969US12163149B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2022·Granted Dec 10, 2024·0 cites·5 claims
- 2068US2015284727A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2013·Application pending·0 cites
- 2167US2025290054A1Target-specific crispr mutantTOOLGEN INC·Filed 2025·Application pending·0 cites
- 2266US11999952B2Artificially-manipulated neovascularization regulatory systemTOOLGEN INC·Filed 2021·Granted Jun 4, 2024·0 cites·11 claims
- 2366US2025064861A1Cells for intravascular transplantation having hemocompatibility, method of producing same, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2463US2025215488A1Method for predicting off-target which can occur in process of editing genome by using prime editing systemTOOLGEN INC·Filed 2023·Application pending·0 cites
- 2563US2024166999A1Hemocompatible mesenchymal stem cells, preparation method therefor and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2663US2024216539A1Vector for delivering active agent to nervous system, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2763US2025000912A1Hypoimmunogenic stem cells, hypoimmunogenic cells differentiated or derived from stem cells and method of preparing sameTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2862US2022228133A1Single base substitution protein, and composition comprising sameTOOLGEN INC·Filed 2020·Application pending·0 cites
- 2962US2023130858A1Target-specific crispr mutantTOOLGEN INC·Filed 2022·Application pending·0 cites
- 3062US2024139254A1Mesenchymal stem cell having oxidative stress resistance, preparation method therefor, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 3162US2020172912A1Genome editing using campylobacter jejuni crispr/cas system-derived rgenTOOLGEN INC·Filed 2019·Application pending·0 cites
- 3261US2025327120A1Method for predicting possible off-targets in gene editing processTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3361US2025115906A1Schwann cell-specific promoterTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3460US11572574B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2020·Granted Feb 7, 2023·0 cites·15 claims
- 3560US2023190889A1Gene editing of anticoagulant factorsTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3659US2025154479A1Streptococcus pyogenes-derived cas9 variantTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3759US2023416315A1Prion-fc region fusion protein and use thereofTOOLGEN INC·Filed 2021·Application pending·0 cites
- 3858US12351838B2Target-specific CRISPR mutantTOOLGEN INC·Filed 2019·Granted Jul 8, 2025·0 cites·11 claims
- 3958US11667934B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2018·Granted Jun 6, 2023·0 cites·15 claims
- 4057US2025146003A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 4157US2020208166A1Oleic Acid-Enriched Plant Body Having Genetically Modified FAD2 And Production Method ThereofTOOLGEN INC·Filed 2017·Application pending·0 cites
- 4254US2025051749A1Novel promoter and use thereofTOOLGEN INC·Filed 2022·Application pending·0 cites
- 4354US2009176653A1Zinc finger domain librariesTOOLGEN INC·Filed 2008·Application pending·0 cites
- 4454US2025283102A1METHOD FOR PRODUCING POTATO PLANT WITH SUPPRESSED BROWNING USING CRISPR/Cas9 SYSTEMTOOLGEN INC·Filed 2021·Application pending·0 cites
- 4553US12331086B2Artificially engineered SC function control systemTOOLGEN INC·Filed 2017·Granted Jun 17, 2025·0 cites·5 claims
- 4652US2023063739A1Cells having high adaptability under hypoxic conditions, and use thereofTOOLGEN INC·Filed 2021·Application pending·0 cites
- 4750US2006251643A1Regulatory zinc finger proteinsTOOLGEN INC·Filed 2003·Application pending·0 cites
- 4849US12012598B2Manipulated immunoregulatory element and immunity altered therebyTOOLGEN INC·Filed 2017·Granted Jun 18, 2024·0 cites·4 claims
- 4948US12275963B2Artificially manipulated immune cellTOOLGEN INC·Filed 2018·Granted Apr 15, 2025·0 cites·13 claims
- 5048US2018237771A1Artificially-Manipulated Neovascularization Regulatory SystemTOOLGEN INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →